In this context we have found that the nuclear pore component Nup153 plays a key role in the aberrant estrogen response of prostate cancer, promoting the nuclear import of important determinants of transcription such as ERβ and eNOS which have been demonstrated to cooperate in driving the pathological gene signature. The gene discussed is ESR2; the disease is prostate carcinoma.